Stay updated on Adjuvant Nivolumab for Stage II Melanoma Clinical Trial

Sign up to get notified when there's something new on the Adjuvant Nivolumab for Stage II Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Adjuvant Nivolumab for Stage II Melanoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The History page now shows a new revision entry (v3.3.2) and removes the previous revision (v3.3.1). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T16:38:56.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    A new revision entry v3.3.1 was added to the Study Record Versions, and the previous v3.2.0 entry was removed.
    Difference
    0.1%
    Check dated 2025-11-24T12:37:32.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The page no longer displays a government funding/operating status notice that was previously shown as a general site-wide alert. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2025-11-17T06:21:17.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    The two screenshots show the same version history table with no data added or removed; the differences are limited to layout and styling. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T01:04:37.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    - Added a government operating status notice and a link to official sources for NIH Clinical Center status. - Updated version to v3.2.0 and removed reference to v3.1.0.
    Difference
    12%
    Check dated 2025-10-05T09:56:37.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    - Updated the revision from v3.0.2 to v3.1.0, indicating a new software version. - No other substantive content changes are evident from the additions and deletions. If there are feature or pricing changes, they are not visible in the provided text.
    Difference
    0.3%
    Check dated 2025-09-28T03:12:24.000Z thumbnail image

Stay in the know with updates to Adjuvant Nivolumab for Stage II Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Adjuvant Nivolumab for Stage II Melanoma Clinical Trial page.